Literature DB >> 26670827

A Comparison of Different Corneal Iontophoresis Protocols for Promoting Transepithelial Riboflavin Penetration.

Daniel M Gore1, David P O'Brart2, Paul French3, Chris Dunsby4, Bruce D Allan1.   

Abstract

PURPOSE: To measure corneal riboflavin penetration using different transepithelial iontophoresis protocols.
METHODS: Freshly enucleated rabbit eyes were divided into nine treatment groups of 4 eyes. One group, in which 0.1% wt/vol riboflavin was applied for 30 minutes without iontophoresis after corneal epithelial debridement, acted as a control. The remaining groups were treated with an intact epithelium using different riboflavin formulations and varying iontophoresis current, soak, and rinse times. After riboflavin application, eyes were snap frozen in liquid nitrogen. Corneal cross sections 35 μm thick were then imaged immediately by two-photon fluorescence microscopy, using image processing software to quantify stromal riboflavin concentration at different corneal depths.
RESULTS: In the epithelium-on iontophoresis treatment groups, greater stromal riboflavin penetration was achieved with higher-concentration riboflavin solutions, greater iontophoresis dosage, and longer solution contact times. A protocol utilizing 0.25% wt/vol riboflavin with benzalkonium chloride (BAC) 0.01% and two cycles of applied current and subsequent soaking (1 mA 5 minutes, soak 5 minutes; 0.5 mA 5 minutes, soak 5 minutes) achieved similar stromal riboflavin penetration to epithelium-off controls. The best-performing non-BAC-containing protocol produced stromal riboflavin penetration approximately 60% that of epithelium-off controls. Riboflavin solutions containing saline resulted in minimal stromal penetration. Riboflavin loading within the epithelium was equivalent to or higher than that in the subjacent stroma, despite rinsing the ocular surface with balanced salt solution.
CONCLUSIONS: Modified iontophoresis protocols can significantly improve transepithelial riboflavin penetration in experimental corneal collagen cross-linking.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26670827     DOI: 10.1167/iovs.15-17569

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Efficacy of iontophoresis-assisted epithelium-on corneal cross-linking for keratoconus.

Authors:  Hong-Zhen Jia; Xiu-Jun Peng
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

2.  Dual-Phase Iontophoresis for the Delivery of Antisense Oligonucleotides.

Authors:  Daniel J Gibson; Sonal S Tuli; Gregory S Schultz
Journal:  Nucleic Acid Ther       Date:  2017-04-04       Impact factor: 5.486

3.  Comparison between standard and transepithelial corneal crosslinking using a theranostic UV-A device.

Authors:  Giuseppe Lombardo; Sebastiano Serrao; Marco Lombardo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-03       Impact factor: 3.117

Review 4.  Nonlinear optical crosslinking (NLO CXL) for correcting refractive errors.

Authors:  Samantha Bradford; Eric Mikula; Tibor Juhasz; Donald J Brown; James V Jester
Journal:  Exp Eye Res       Date:  2020-08-23       Impact factor: 3.467

5.  The Effect of Sodium Iodide on Stromal Loading, Distribution and Degradation of Riboflavin in a Rabbit Model of Transepithelial Corneal Crosslinking.

Authors:  Roy S Rubinfeld; Glenwood G Gum; Jonathan H Talamo; Edward C Parsons
Journal:  Clin Ophthalmol       Date:  2021-05-11

6.  An Investigation of the Effects of Riboflavin Concentration on the Efficacy of Corneal Cross-Linking Using an Enzymatic Resistance Model in Porcine Corneas.

Authors:  Naomi A L O'Brart; David P S O'Brart; Nada H Aldahlawi; Sally Hayes; Keith M Meek
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

7.  Enhanced Transepithelial Riboflavin Delivery Using Femtosecond Laser-Machined Epithelial Microchannels.

Authors:  Samantha Bradford; Eric Mikula; Yilu Xie; Tibor Juhasz; Donald J Brown; James V Jester
Journal:  Transl Vis Sci Technol       Date:  2020-05-11       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.